Coherence principles in dose-finding studies

Biometrika

Volumn 92, Issue 4, 2005, Pages 863-873

  Cheung, Ying Kuen ^a  

^a Columbia University ^*  (United States)

Author keywords

Compatibility; Grouped accrual; Phase I trial; Two stage design

Indexed keywords

EID: 27944494441     PISSN: 00063444     EISSN: 14643510     Source Type: Journal    
DOI: 10.1093/biomet/92.4.863     Document Type: Review

References (11)

1. BABB, J., ROGATKO, A. & ZACKS, S. (1998). Cancer phase I clinical trials: efficient dose escalation with overdose control. Statist. Med. 17, 1103-20.
2. CHEUNG, Y. K. & CIIAPPELL, R. (2000). Sequential designs for phase I clinical trials with late-onset toxicities. Biometrics 56, 1177-82.
3. CHEUNG, Y. K. & CHAPPELL, R. (2002). A simple technique to evaluate model sensitivity in the continual reassessment method. Biometrics 58, 671-4.
4. DURHAM, S. D., FLOURNOY, N. & ROSENBERGER, W. F. (1997). A random walk rule for phase I clinical trials. Biometrics 53, 745-60.
5. GASPARINI, M. & EISELE, J. (2000). A curve-free method for phase I clinical trials. Biometrics 56, 609-15.
6. McLEISH, D. L. & TOSH, D. (1990). Sequential designs in bioassay. Biometrics 46, 103-16.
7. MØLLER, S. (1995). An extension of the continual reassessment methods using a preliminary up-and-down design in a dose finding study in cancer patients, in order to investigate a greater range of doses. Statist. Med. 14, 911-22.
8. O'QUIGLEY, J., PEPE, M. & FISHER, L. (1990). Continual reassessment method: a practical design for phase I clinical trials in cancer. Biometrics 46, 33-48.
9. SHEN, L. Z. & O'QUIGLEY, J. (1996). Consistency of continual reassessment method under model misspecification. Biometrika 83, 395-405.
10. THALL, P. F., INOUE, L. Y. T. & MARTIN, T. (2002). Adaptive decision making in a lymphocyte infusion trial. Biometrics 58, 560-8.
11. WU, C. F. J. (1985). Efficient sequential designs with binary data. J. Am. Statist. Assoc. 80, 974-84.